# Shire Human Genetic Therapies, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/7051823d-8cc7-4d72-8a82-a0de9bbb9497

> Inspection records and compliance data for Shire Human Genetic Therapies, Inc. in Lexington, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Shire Human Genetic Therapies, Inc.
- FEI Number: 3009340644
- City: Lexington
- State: Massachusetts
- Country Name: United States
- Address Line 1: 300 Shire Way
- Zip Code: 02421

## Related Documents

- [483 - Shire Human Genetic Therapies, Inc. - 2025-12-18](https://www.keypedia.com/records/483/shire-human-genetic-therapies-inc/b6961644-a238-49ea-bb11-3339d61c8541) — source: FDA, date: December 18, 2025
- [FDA Inspection 1297340 - Shire Human Genetic Therapies, Inc. - 2025-12-18](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/b66e1add-a72b-454b-ae49-945906abc3d0) — source: FDA, date: December 18, 2025
- [FDA Inspection 1297340 - Shire Human Genetic Therapies, Inc. - 2025-12-18](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/73796886-ab22-4568-9656-3ab5772ef0a5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2025
- [483 - Shire Human Genetic Therapies, Inc. - 2022-04-22](https://www.keypedia.com/records/483/shire-human-genetic-therapies-inc/91b0c891-d7c9-41c4-856e-464b842ee491) — source: FDA, date: April 22, 2022
- [483 - Shire Human Genetic Therapies, Inc. - 2022-04-22](https://www.keypedia.com/records/483/shire-human-genetic-therapies-inc/43f8e360-2187-4f47-8b0a-0a87875029db) — source: FDA, date: April 22, 2022
- [FDA Inspection 1167818 - Shire Human Genetic Therapies, Inc. - 2022-04-22](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/51a7a629-d932-45eb-bf64-a0a15b005f76) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 22, 2022
- [483 - Shire Human Genetic Therapies, Inc. - 2022-03-23](https://www.keypedia.com/records/483/shire-human-genetic-therapies-inc/b0a0181d-afc7-4c9c-a6b0-5e0abb947400) — source: FDA, date: March 23, 2022
- [FDA Inspection 1116968 - Shire Human Genetic Therapies, Inc. - 2020-01-15](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/1ae8f893-5541-4ec2-bd26-a3c8369df807) — classification: No Action Indicated (NAI), source: FDA, date: January 15, 2020
- [FDA Inspection 1061705 - Shire Human Genetic Therapies, Inc. - 2018-07-25](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/48bf3ed1-b711-4574-91fe-82f89a3e920c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2018
- [FDA Inspection 1004081 - Shire Human Genetic Therapies, Inc. - 2017-01-20](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/2ca1a688-015e-49e3-aa51-cf11d1e11acc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 20, 2017
- [FDA Inspection 982412 - Shire Human Genetic Therapies, Inc. - 2016-07-28](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/ba1064c5-fd00-4de9-8054-3dc0dd0f658b) — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2016
- [FDA Inspection 944256 - Shire Human Genetic Therapies, Inc. - 2015-08-14](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/cdf40c6e-d2b9-470a-9ecc-ea1dd018e32e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 14, 2015
- [FDA Inspection 939368 - Shire Human Genetic Therapies, Inc. - 2015-07-15](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/56029fd9-287f-42c6-9c37-df7773bc659f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2015
- [FDA Inspection 891161 - Shire Human Genetic Therapies, Inc. - 2014-08-06](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/53df6c03-1cc0-4651-929a-bcd62e809e22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 6, 2014

## Related Companies

- [Fournier Laboratories Ireland, Ltd. (Abbvie Cork)](https://www.keypedia.com/companies/fournier-laboratories-ireland-ltd-abbvie-cork/1cceaab0-3bd3-40ff-b7e3-5b180f1fc3a4)
- [Towa Pharmaceutical Europe, S.L.](https://www.keypedia.com/companies/towa-pharmaceutical-europe-sl/731d0b47-ce02-4781-8582-7090b456c5fe)
- [J. B. Chemicals and Pharmaceuticals Limited](https://www.keypedia.com/companies/j-b-chemicals-and-pharmaceuticals-limited/d77ff966-bfe4-483b-8ca9-723a59fcaba5)
- [ZYDUS LIFESCIENCES LIMITED](https://www.keypedia.com/companies/zydus-lifesciences-limited/aa40e2a7-c250-4524-b05f-6ca311474c5c)
- [Catalent Argentina S.A.I.C.](https://www.keypedia.com/companies/catalent-argentina-saic/c4e097df-85fe-4836-9778-b395fe1e78de)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/0de1df3a-c70c-43b9-9a35-4aac9b0413f4)
- [Lead Chemical Co., Ltd.](https://www.keypedia.com/companies/lead-chemical-co-ltd/b8997674-3f8e-4cd9-8f7d-1c677f4ea0f0)
- [Rockledge Pharmaceutical Manufacturing LLC](https://www.keypedia.com/companies/rockledge-pharmaceutical-manufacturing-llc/a5456e96-65d2-4f19-ba2f-e7cb72b32922)
- [Conopco, Inc](https://www.keypedia.com/companies/conopco-inc/7ea57e14-27dd-432e-a45a-5af402cdb9e5)
- [MW Encap Ltd.(NextPharma Edinburgh)](https://www.keypedia.com/companies/mw-encap-ltdnextpharma-edinburgh/e8cf1af5-d17a-4c79-ba7d-498a371fbc50)

## Related Officers

- [company_representative](https://www.keypedia.com/people/scott-lee/337531e8-7f7a-4131-9114-f4074aef421b)
- [issuing_officer](https://www.keypedia.com/people/charles-y-kuo/36d44416-c980-4b33-b62e-ea0761a46a46)
- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)
- [Vice President and Head MA Bio Ops.](https://www.keypedia.com/people/james-m-payne/a00b1219-b005-4eca-8f3b-cf5f84573aee)